Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain.
about
Recent developments of protein kinase inhibitors as potential AD therapeuticsPresenilin 1 associates with glycogen synthase kinase-3beta and its substrate tauRegulation of mitochondrial functions by protein phosphorylation and dephosphorylationGlycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and ImagingNeuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathwaysMolecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisalStructural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418Mood stabilizers, glycogen synthase kinase-3beta and cell survivalGSK3beta in ethanol neurotoxicityThe role of GSK3beta in the development of the central nervous systemLight and electron microscopy study of glycogen synthase kinase-3beta in the mouse brainGSK-3: Functional Insights from Cell Biology and Animal Models.Abnormalities in brain structure and behavior in GSK-3alpha mutant miceA ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's diseaseRapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation.Improvement by nefiracetam of beta-amyloid-(1-42)-induced learning and memory impairments in rats.Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axinStable isotope-resolved metabolomic analysis of lithium effects on glial-neuronal metabolism and interactionsMicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's diseaseGlycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53.Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease.What Are the bona fide GSK3 Substrates?Bioenergetics breakdown in Alzheimer's disease: targets for new therapiesLarge-scale in silico modeling of metabolic interactions between cell types in the human brain.Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3betaInhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition.A model for dynamic regulation of choline acetyltransferase by phosphorylation.GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling.D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's diseaseThe GSK3 hypothesis of Alzheimer's diseaseRegulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration.The marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling.Mitochondrial hyperpolarization in iPSC-derived neurons from patients of FTDP-17 with 10+16 MAPT mutation leads to oxidative stress and neurodegeneration.Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations.Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway.The pyruvate dehydrogenase complex as a therapeutic target for age-related diseases.GSK-3 and mitochondria in cancer cells.Regulation of pyruvate metabolism in metabolic-related diseases.GSK-3β, a pivotal kinase in Alzheimer disease.The mitochondrial permeability transition pore and its adaptive responses in tumor cells.
P2860
Q21129481-789E303B-8404-4C2A-BE3A-B4A50DF25441Q24320124-D5359CCB-A9D1-4134-A5ED-775B0B04BEFCQ26752880-4665A566-57B1-4781-85D1-F6E818044A89Q26768475-8EB575C7-1D82-47BD-AF54-4AB119B16513Q26779424-31596831-8316-4878-B4EC-7D7A3FE38112Q26783344-C41E2688-A8C0-423C-A771-C7806F93AB28Q27641873-982E2DE9-D55F-4677-BB69-E0186422C9D5Q28216404-E31F7E2B-1CAF-4490-82BF-F9C952EA3B86Q28387181-47E0CDCE-A30B-459A-A583-36AE79EF2971Q28387853-8881284B-1DDF-4ED7-A412-FF1916F3DDB7Q28472669-903E4863-CFD8-4170-B680-48FCB9447D56Q30472813-42140727-03FC-41E3-9CFC-4172F586E60BQ30485018-BD49DF8D-4E20-4359-9C24-0076F1F38802Q30538459-3A1499D0-01AB-42D4-981A-75656BDA5D59Q31034955-BA47084B-857F-4655-83B8-8AFC66C46233Q33853596-D935F217-8841-459A-8AA4-F48BE0F5C847Q33959834-77B9C51D-B051-4C1A-B5D7-D0E6C24C2D8AQ33989596-E4D34E8C-A78E-4DFC-95F5-FC3CD81B881CQ34324544-DFE6054D-D315-45EA-A561-10C07AE4BD2FQ34338748-DA20A165-B134-4468-ACB7-A19B5D406001Q34785749-EA64CFBE-4F26-4A3E-B520-BA198DBA3E44Q35001234-A6B59B16-3CF8-46F6-ABC1-ABC575A15EF0Q35098445-884AE57A-EB50-481C-BFCD-1F8D925451BFQ35117087-3C411F48-CF1B-4802-842D-F63A927E542AQ35142950-B03AC4BF-0DD0-4D7F-A1F4-70C3FB050228Q36158687-8C519011-D7FC-40FA-BF6E-0C8B7BB231F5Q36245818-EA5C66FF-876D-450E-829D-9D3AC8CAAC46Q36378223-CF9FFC60-CA4A-4158-9223-84ACD014D86AQ36976707-B6F3F3E7-D50F-4F7B-842A-2A37812340A8Q37035378-A55A259E-9513-466B-A5CF-5C5666A21CDBQ37273048-00986D71-5E65-481C-BE85-C6B5BAB574DBQ37345648-C21B2DE3-6017-4DBC-9DC1-F2C82514C8C2Q37710447-6569EF97-C61E-43D2-B4E3-50C48E945DA8Q37789771-AC180307-1BA1-4ADC-814C-FBF061E0DB21Q37883102-9246790E-98C1-4E37-B55E-FC175AE2DA34Q37982890-7F74339B-C337-4E56-AE42-2FE61C105309Q38079592-57B4F3BD-BB73-4AF6-B1D1-909AE05ED9C0Q38161453-AE210E6B-94F1-40FF-94D2-99765F6B51ADQ38218085-6218E778-4E1F-498E-B7B5-6EC8B50AB5F1Q38278265-7066DBD9-4C74-4DBB-BF6B-EA4427676EAD
P2860
Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulation of mitochondrial py ...... ynthase kinase 3beta in brain.
@en
Regulation of mitochondrial py ...... ynthase kinase 3beta in brain.
@nl
type
label
Regulation of mitochondrial py ...... ynthase kinase 3beta in brain.
@en
Regulation of mitochondrial py ...... ynthase kinase 3beta in brain.
@nl
prefLabel
Regulation of mitochondrial py ...... ynthase kinase 3beta in brain.
@en
Regulation of mitochondrial py ...... ynthase kinase 3beta in brain.
@nl
P2093
P2860
P356
P1476
Regulation of mitochondrial py ...... ynthase kinase 3beta in brain.
@en
P2093
Ishiguro K
Murayama M
Takashima A
P2860
P304
P356
10.1073/PNAS.93.7.2719
P407
P577
1996-04-01T00:00:00Z